Lycopene and myocardial infarction risk in the EURAMIC study

American Journal of Epidemiology

Volumn 146, Issue 8, 1997, Pages 618-626

  Kohlmeier, Lenore ^a,l   Kark, Jeremy D ^b   Gomez Gracia, Enrique ^c   Martin, Biaise C ^d   Steck, Susan E ^e   Kardinaal, Alwine F M ^f   Ringstad, Jetmund ^g   Thamm, Michael ^a   Masaev, Victor ^h   Riemersma, Rudolf ⁱ   Martin Moreno, José M ^j   Huttunen, Jussi K ^k   Kok, Frans J ^f  

^a Institute for Medical Statistics and Clinical Epidemiology   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f TNO   (Netherlands)

^g Ostfold Central Hospital   (Norway)

^h NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

^j INSTITUTO DE SALUD CARLOS III   (Spain)

^k NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^l IL   (United States)

more..

Author keywords

Adipose tissue; Carotene; Carotenoids; Myocardial infarction

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; LYCOPENE;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DIET; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS;

EID: 0030723740     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009327     Document Type: Article

References (34)

1. Stamler J. Opportunities and pitfalls in international comparisons related to patterns, trends, and determinants of CEID mortality. Int J Epidemiol 1989;18(suppl 1):S3-18.
2. Artaud-Wild SM, Connor SL, Sexton G, et al. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland: a paradox. Circulation 1993;88:2771-9.
3. Heller RF, Chinn S, Tunstall-Pedoe TID, et al. How well can we predict heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J 1984;288:110-23.
4. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
5. Goldstein JL, Ho YK, Basu SK, et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333-7.
6. Slyper AH. Low-density lipoprotein density and atherosclerosis. Unraveling the connection. JAMA 1994;272:305-8.
7. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
8. Frei B. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation. Crit Rev Food Sci Nutr 1995;351:83-98.
9. Gaziano J, Michael C, Hennekens H. The role of β-carotene in the prevention of cardiovascular disease. Ann N Y Acad Sci 1993;691:148-55.
10. Holvoet P, Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 1994;8:1279-84.
11. Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1984;1:1396-7.
12. Gey KF, Moser UK, Jordan P, et al. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993;57(suppl):787S-97S.
13. Riemersma RA, Oliver M, Elton RA, et al. Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. Eur J Clin Nutr 1990;44:143-50.
14. Riemersma RA, Wood DA, MacIntryre CCA, et al. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;337:1-5.
15. Kardinaal AF, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study. Lancet 1993;342:1379-84.
16. Street DA, Comstock GW, Salkeld RM, et al. A population- based case-control study of the association of serum antioxidants and myocardial infarction. Am J Epidemiol 1991;134:719-20.
17. Kok FJ, De Bruijn AM, Vermeeren R, et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:1368-77.
18. Kushi LH, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334:1156-62.
19. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
20. Ommen GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
21. Hennekens CH, During JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
22. Women's Health Study Research Group. The Women's Health Study: summary of the study design. J Myocardial Ischemia 1992;4:27-9.
23. Manson JE, Gaziano JM, Spelspberg A, et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: rationale, design, and methods. Ann Epidemiol 1995;5:261-9.
24. Kardinaal AFM, van't Veer P, Kok FJ, et al. EURAMIC Study: antioxidants, myocardial infarction, and breast cancer. Eur J Clin Nutr 1993;47(suppl 2):64-71.
25. Beynen AC, Katan MB. Rapid sampling and long-term storage of subcutaneous adipose-tissue biopsies for determination of fatty acid composition. Am J Clin Nutr 1985;42:317-22.
26. Statistical Analysis System, Inc. SAS statistics, 4th ed. Version 6. Cary, NC: Statistical Analysis System, Inc, 1990:1364.
27. Kleinbaum DG, Kupper LL, Morgenstern H, eds. Epidemiologic research. Principles and quantitative methods. Belmont, CA: Wadsworth, Inc, 1982.
28. Stahl W, Schwarz W, Sundquist AR, et al. cis-trans isomers of lycopene and beta-carotene in human serum and tissues. Arch Biochem Biophys 1992;294:173-7.
29. Kohlmeier L, Kohlmeier M. Adipose tissue as a medium for epidemiologic exposure assessment. Environ Health Perspect 1995;103(suppl 3):99-106.
30. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76.
31. DiMascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274:532-8.
32. Esterbauer H, Striegl G, Puhl H, et al. Role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann N Y Acad Sci 1989;70:254-67.
33. Ribaya-Mercado JD, Garmyn M, Gilchrest BA, et al. Skin lycopene is destroyed preferentially over beta-carotene during ultraviolet irradiation in humans. J Nutr 1995;125:1854-9.
34. Handelman GJ, Epstein WL, Peerson J, et al. Human adipose alpha-tocopherol and gamma-tocopherol kinetics during and after 1 y of alpha-tocopherol supplementation. Am J Clin Nutr 1994;59:1025-32.